Palladacycle (BPC) antitumour activity against resistant and metastatic cell lines: the relationship with cytosolic calcium mobilisation and cathepsin B activity

Palladacycle (BPC) antitumour activity against resistant and metastatic cell lines: the relationship with cytosolic calcium mobilisation and cathepsin B activity

Author Bechara, Alexandre Autor UNIFESP Google Scholar
Barbosa, Christiano M. V. Autor UNIFESP Google Scholar
Paredes-Gamero, Edgar J. Autor UNIFESP Google Scholar
Garcia, Daniel M. Autor UNIFESP Google Scholar
Silva, Luis S. Autor UNIFESP Google Scholar
Matsuo, Alisson L. Autor UNIFESP Google Scholar
Nascimento, Fabio D. Google Scholar
Rodrigues, Elaine G. Autor UNIFESP Google Scholar
Caires, Antonio C. F. Google Scholar
Smaili, Soraya Soubhi Autor UNIFESP Google Scholar
Bincoletto, Claudia Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Univ Bandeirante São Paulo UNIBAN
Univ Mogi das Cruzes
Abstract The search for new compounds that induce p53-independent apoptosis is the focus of many studies in cancer biology because these compounds could be more specific and would overcome chemotherapy resistance. in this study, we evaluated the in vitro antitumour activity of a Biphosphinic Palladacycle Complex (BPC) and extended preclinical studies to an in vivo model. Saos-2 cells, a p53-null human osteosarcoma drug-resistant cell line, were treated with BPC in the presence or absence of a cathepsin B inhibitor and a calcium chelator (CA074 and BAPTA-AM, respectively), and several parameters related to apoptosis were evaluated. Preclinical studies were performed with mice that were intravenously inoculated with murine melanoma Bl6F10-Nex2 cells and treated intraperitoneally (i.p.) with BPC (8 mg/kg/ day) for ten consecutive days, when lung metastatic nodules were counted. in vitro data show that BPC induces cell death in Saos-2 cells mainly by apoptosis, which was accompanied by the effector caspase-3 activation. These events are most likely related to Bax translocation and increased cytosolic calcium mobilisation, mainly from intracellular compartments. Lysosomal Membrane Permeabilisation (LMP) was also observed after 12 h of BPC exposure. Interestingly, BAPTA-AM and CA074 significantly decreased BPC cytotoxicity, suggesting that both calcium and cathepsin B are required for BPC antitumour activity. in vivo studies demonstrated that BPC protects mice against murine metastatic melanoma. in conclusion, BPC complex is an effective anticancer compound against metastatic murine melanoma. This complex is cytotoxic to the drug-resistant osteosarcoma Saos-2 human tumour cells by inducing apoptosis triggered by calcium signalling and a lysosomal-dependent pathway. (C) 2014 Elsevier Masson SAS. All rights reserved.
Keywords Cytotoxicity
Biphosphinic Palladacycle Complex
Anticancer compounds
Calcium signalling
Lysosomal Membrane Permeabilisation
Cathepsin B
Language English
Sponsor Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Grant number FAPESP: 10/51647-6
Date 2014-05-22
Published in European Journal of Medicinal Chemistry. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 79, p. 24-33, 2014.
ISSN 0223-5234 (Sherpa/Romeo, impact factor)
Publisher Elsevier B.V.
Extent 24-33
Access rights Closed access
Type Article
Web of Science ID WOS:000336700600003

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account